On September 17, Rivkin Radler’s Jeff Kaiser will participate on a panel at the Practising Law Institute (PLI) “Life Sciences 2026: Navigating Legal Challenges in Drug and Device Industries” program in New York City. The panel is entitled “Enforcement Trends Impacting the Drug and Device Industries.”
Offered virtually and at PLI’s NY Conference Center at 1177 Avenue of the Americas, the program provides a practical look at recent legal and regulatory developments and issues shaping the drug and device industries. Panelists will discuss:
- changes to FDA policies and practices
- AI governance strategies for effective AI use in the life sciences industry
- pharmaceutical and medical device coverage and reimbursement
- enforcement trends
- effective compliance programs and investigations in the current environment
For information and to register, click here.